Hepatitis C can now be cured in 95% of cases, with no painful side effects.​

Getting treatment is easy! ​

Step 1 ​
Book an appointment at one of our C-Ya! Project Outreach clinics. ​

Step 2 ​
A short consultation with a health professional which will include a blood test and liver check.​

Step 3 ​
If diagnosed with HCV, treatment with Direct Acting Antiviral tablets takes just 8-12 weeks.​

Then, you can say C-YA! to Hep’ C

About the C-YA! Project

The C-YA! Project aims to eliminate the deadly Hepatitis C virus (HCV) from people returning to society after a period of incarceration. ​

Our goal is to make curative treatment as easy as possible for this high-risk population, so we take our service to them – operating out of Beenleigh and Logan Central Queensland Corrective Service offices. ​

Treatments are private and discreet and our staff take the utmost care to meet the individual needs of each patient. Best of all, it’s free to access and the medication is affordable as it is covered under the Pharmaceutical Benefits Scheme.​

The project provides all the support you need to say C-YA! to the virus when you are looking to start a new life after incarceration. ​

The C-YA! Project is funded by the Gilead Fellowship, whose aim is to support innovative local research initiatives to improve patient outcomes, in particular in the understanding of HIV, chronic viral hepatitis, haematological malignancies, non-alcoholic steatohepatitis (NASH), inflammatory diseases and invasive fungal infection. Their grants program funds projects with a real-world focus that are committed to the development and implementation of best practice to enhance patient outcomes.

HCV is a blood-borne virus and is most commonly transmitted through shared injecting equipment.​

Viral hepatitis is a leading cause of mortality resulting in 1.46 million deaths worldwide in 2015.​

The World Health Organisation has set targets to achieve elimination of viral hepatitis by 2030.

Why are incarcerated populations at risk?
The prevalence of HCV in Australian prisons is 30%, increasing to 60% among those who have ever injected drugs.​

It is estimated that the incidence of new HCV infections in prisons is >30 per 100 persons per year.​

If you have ever been in prison and/or shared a needle, you need to get tested!

New Direct Acting Antivral (DAA) therapies for chronic HCV infection are now listed on the Pharmaceutical Benefits Scheme.

Would you like to say C-YA! to Hep’ C?​
Book an appointment with the C-YA! Project today.​

Interested in hosting an outreach clinic at your QCS office?​
Get in touch with the C-YA! Project today.

Follow Us